RETRACTED: Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers

This publication has 25 references indexed in Scilit:

• Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
  Cancer Letters, 2008
• Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level
  Haematologica, 2008
• Curcumin Decreases Specificity Protein Expression in Bladder Cancer Cells
  Cancer Research, 2008
• Cancer Statistics, 2008
  CA: A Cancer Journal for Clinicians, 2008
• Gemcitabine in bladder cancer
  Expert Opinion on Pharmacotherapy, 2007
• A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging
  BJU International, 2007
• Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of IκBα Kinase and Akt Activation
  Molecular Pharmacology, 2006
• Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
  Journal of Clinical Oncology, 2005
• Broad-Spectrum G Protein–Coupled Receptor Antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: A Dual Inhibitor of Growth and Angiogenesis in Pancreatic Cancer
  Cancer Research, 2005
• Protein Farnesyltransferase Inhibitor (SCH 66336) Abolishes NF-κB Activation Induced by Various Carcinogens and Inflammatory Stimuli Leading to Suppression of NF-κB-regulated Gene Expression and Up-regulation of Apoptosis
  Journal of Biological Chemistry, 2004